Understanding any negative effects of current practice and how GPs can better meet the needs of this marginalised group is key to improving safety and care, they concluded
Hoy et al., 2013
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells
PubChem Compound Summary for CID 9941957 PubChem, Gurtner GC, Werner S, Barrandon Y, Longaker MT